| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033494 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033232 Methods and compositions for in vivo clearance of pathogens |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033226 Osteopontin, oligodendrocytes and myelination |
| 02/19/2004 | US20040033218 Extracellular matrix (ecm); cell and genetic therapy |
| 02/19/2004 | US20040033217 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 02/19/2004 | US20040033216 Harvesting the pancreas of piglets at or near full term gestation, and extracting pancreatic beta islet cells exposed to nicotinamide |
| 02/19/2004 | US20040033215 Transferring a cell proliferation factor gene into a mammalian liver cell, for an in vitro immortalized cell, proliferating the immortalized cell, and removing the cell proliferation factor gene |
| 02/19/2004 | US20040033214 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 02/19/2004 | US20040033213 Methods of modulating dendritic cells using adjuvants |
| 02/19/2004 | US20040033212 Isolated population of superficial zone chondroprogenitor cells; replacement of damaged cartilage |
| 02/19/2004 | DE20215659U1 Reagenzienkit zur Kultivierung von Zellen Reagent kit for culturing cells |
| 02/19/2004 | DE10236001A1 Producing transgenic plants transformed in the plastome, by introducing two DNA segments each containing a region homologous with plastome nucleic acid |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2534874A1 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2496002A1 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | CA2495676A1 Innervated artificial tissues and uses thereof |
| 02/19/2004 | CA2495545A1 Plastid transformation using modular vectors |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2495112A1 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | CA2494930A1 Modified forms of interfering rna molecules |
| 02/19/2004 | CA2494928A1 Cancer diagnostics and prognostics |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494675A1 Immunomodulating compositions, processes for their production and uses therefor |
| 02/19/2004 | CA2494252A1 Psmcs as modifiers of the rb pathway and methods of use |
| 02/19/2004 | CA2494236A1 Csnk1gs as modifiers of the p21 pathway and methods of use |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/18/2004 | EP1389292A1 Cryopreservation system with controlled dendritic freezing front velocity |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389234A2 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 02/18/2004 | EP1389233A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/18/2004 | EP1389228A2 0etergent compositions comprising bacillus subtilis pectate lyases |
| 02/18/2004 | EP1389078A2 Processes for making cryopreserved composite living constructs and products resulting therefrom |
| 02/18/2004 | EP1389042A1 Sprr1a and axonal regeneration |
| 02/18/2004 | EP1237408B1 Pour-on formulations |
| 02/18/2004 | EP1178822B1 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells |
| 02/18/2004 | EP1028744B1 Neuronal uses of bmp-11 |
| 02/18/2004 | EP0904396B1 Production of vanillin |
| 02/18/2004 | EP0751995B1 Riboflavin synthesis in fungi |
| 02/18/2004 | EP0731838B1 Binding structures directed against the ca55.1 antigen |
| 02/18/2004 | EP0720482B1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/18/2004 | CN1476483A Modified vaccinia ankara virus variant |
| 02/18/2004 | CN1476481A Isolated luciferases and use thereof |
| 02/18/2004 | CN1476480A Isolated peptides which bind to HLA-C molecules and uses thereof |
| 02/18/2004 | CN1476479A Human protooncogene and protein encoded therein |
| 02/18/2004 | CN1476478A Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/18/2004 | CN1476477A Promoter expressing foreign gene in root and shoot apex |
| 02/18/2004 | CN1475574A Method of preceeding gene conversion against orchid using micropellet bombardment |
| 02/18/2004 | CN1475563A Method of proceeding gene conversion against orchid using agriculturel bacillus induction |
| 02/18/2004 | CN1475498A Preparation of antigen sensitized human dendron shaped cell and its use |
| 02/18/2004 | CN1138859C Infection clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 02/18/2004 | CN1138858C Nuclear-encoded transcription system in plastids of higher plants |
| 02/18/2004 | CN1138786C Antibody for identifying osteoclast forming inhibitor binding protein, and preparing process and use |
| 02/18/2004 | CN1138785C Application of growth factor neuregulin and its analogs |
| 02/18/2004 | CN1138472C Dipeptide apoptosis inhibitors and use thereof |
| 02/18/2004 | CN1138466C Method for culturing pure laver line |
| 02/17/2004 | US6693185 Genetic engineering |
| 02/17/2004 | US6693183 MURINE α (1,3) FUCOSYLTRANSFERASE FUC-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID |
| 02/17/2004 | US6693181 Protein secretion |
| 02/17/2004 | US6693172 Isolated polypeptide amino acid sequence 14; measuring cellular ion channel transmission; identification of ligand gated agonists and modulators |
| 02/17/2004 | US6693171 ACPL polypeptides |
| 02/17/2004 | US6693081 Bone stimulating factor |
| 02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
| 02/17/2004 | US6692966 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 02/17/2004 | US6692965 Exposing to molecular beacon comprised of nucleotides complementary to rna of interest; isolating cells that fluoresce upon hybridization |
| 02/17/2004 | US6692963 Method of reproducing plants by somatic embryogenesis |
| 02/17/2004 | US6692961 Heparin, epidermal and fibroblast growth factors and agent that increases intracellular levels of cyclic adenosine monophosphate; replacements for organ or gland extracts |
| 02/17/2004 | US6692960 Gene expression inhibition; treating developmental disorders or aberrant apoptosis |
| 02/17/2004 | US6692959 Hybrid nucleic acids; prevent, controlling gene expression; antiinflammatory agents |
| 02/17/2004 | US6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 02/17/2004 | US6692957 Isolation of preferential aggregates in sample; obtain aggregates, transform, isolate aggregates expressing green fluorescent protein |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692955 HIV vaccine |
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | US6692938 Peptide for use in the treatment of inflammation, arthritis, glomerulonephritis, asthma, psoriasis, viral infections, cancer, atherosclerosis, leukemia and autoimmune diseases |
| 02/17/2004 | US6692937 Nucleotide sequences coding membrane protein for use in the treatment of cancer, infection and heart defects |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692935 Fusion of peptide or protein association domains designed to assemble in a complementary fashion, thereby providing multifunctional (poly)peptides |
| 02/17/2004 | US6692932 Thermostable DNA polymerase from anaerocellum thermophilum |
| 02/17/2004 | US6692929 Polypeptide; for use in detection of cell cycle modulators |
| 02/17/2004 | US6692918 Amplification of prferential nucleotide sequences; obtain nucleotide sequences, denature, incubate with primer and polymerase, amplify, recover nucleotide sequences |
| 02/17/2004 | US6692908 Prevention and treatment of HCV infection employing antibodies that inhibit the interaction of HCV virions with their receptor |
| 02/17/2004 | US6692761 Polyesterether copolymer; biodegradation; biocopatibility; porous membranes |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692748 Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 |
| 02/17/2004 | US6692747 Peptide for use in the treatment of infections, viral and cancer diseases |
| 02/17/2004 | US6692746 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 02/17/2004 | US6692744 Betaglycan as an inhibin receptor and uses thereof |
| 02/17/2004 | US6692741 Treatment of acute lung injury and fibrosis with antagonists of β6-specific antibodies |
| 02/17/2004 | US6692740 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
| 02/17/2004 | US6692738 Implanting cell-matrix structure comprising matrix having attached thereto an effective amount of cells stably expressing a gene encoding biological modifier to stop or regress the excessive tissue proliferation |
| 02/17/2004 | US6691638 Increasing the proportion of male chicks in chicken eggs by reducing the germ cells of female in ovo with busulfan, introducing male avian primordial germ cells into female bird in ovo; raising bird to maturity and breeding |
| 02/17/2004 | US6691457 Floral packaging material having great masters prints thereon |
| 02/17/2004 | CA2274122C Improved chondrogenic differentiation of human mesenchymal stem cells |